Effective management of bacterial diseases in livestock and horses is crucial for maintaining herd health, productivity, and economic viability. Ceftiofur Sodium, a potent third-generation cephalosporin antibiotic, has emerged as a leading therapeutic agent for a wide range of infections in these valuable animal populations. This article explores the specific applications and recommended dosages of Ceftiofur Sodium for common ailments affecting cattle, swine, sheep, goats, and horses.

In cattle, Ceftiofur Sodium is a frontline treatment for bovine respiratory disease (BRD), a complex multifactorial disease often initiated by viral infections and complicated by bacterial pathogens. The Ceftiofur Sodium dosage for cattle typically involves 1.0 mg of ceftiofur per kg of body weight administered intramuscularly once daily for three consecutive days. This dosage regimen has proven effective against key BRD pathogens such as Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni. Furthermore, for acute bovine interdigital necrobacillosis (foot rot), Ceftiofur Sodium is administered at similar dosages, targeting Fusobacterium necrophorum and Bacteroides melaninogenicus, thereby improving animal welfare and preventing economic losses due to lameness.

For swine, the focus is often on controlling and treating bacterial respiratory diseases, commonly known as swine bacterial pneumonia. Actinobacillus pleuropneumoniae and Pasteurella multocida are frequent culprits. The Ceftiofur Sodium swine bacterial pneumonia treatment typically involves dosages ranging from 3.0 to 5.0 mg ceftiofur per kg of body weight, administered intramuscularly once daily for three days. Adherence to these Ceftiofur Sodium treatment protocols is vital for successful eradication of the disease from a herd.

Sheep and goats also benefit from Ceftiofur Sodium, particularly for respiratory infections. Similar to cattle, a dosage of 1.1 to 2.2 mg ceftiofur per kg of body weight is recommended, administered intramuscularly daily for three consecutive days. The selection of dosage within this range should be guided by the severity of the disease, taking into account clinical signs like elevated temperature, respiratory distress, and appetite loss.

In the realm of equine health, Ceftiofur Sodium is specifically indicated for respiratory infections in horses associated with Streptococcus zooepidemicus. The recommended Ceftiofur Sodium dosage for horses is higher, typically 2.2 to 4.4 mg ceftiofur per kg of body weight, administered intramuscularly every 24 hours. Treatment duration is crucial, with administration continuing for 48 hours after clinical signs have resolved, but not exceeding 10 days. This targeted approach ensures effective bacterial clearance and recovery.

The availability of Ceftiofur Sodium as a sterile powder for injection necessitates proper reconstitution and aseptic technique. Veterinarians must reconstitute the powder with the appropriate diluent to achieve the desired concentration, usually 50 mg/mL. The choice between intramuscular and subcutaneous injection depends on the species and the specific indication, as detailed in the product's prescribing information.

Understanding the Ceftiofur Sodium withdrawal period is also critical for food-producing animals. For cattle and lambs, no meat withdrawal period or milk withholding time is required when used according to label directions. However, horses treated with Ceftiofur Sodium must not be slaughtered for human consumption. These guidelines ensure compliance with food safety regulations.

In summary, Ceftiofur Sodium is a powerful and versatile antibiotic that plays a pivotal role in veterinary medicine. Its precise application and adherence to recommended dosages for cattle, swine, sheep, goats, and horses are key to its efficacy in combating a range of bacterial infections and maintaining animal health.